Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Mitsuhiko, Iwamoto"'
Autor:
Noriaki Kataoka, Takeo Hata, Kouichi Hosomi, Atsushi Hirata, Ryosuke Ota, Masami Nishihara, Kosei Kimura, Mitsuhiko Iwamoto, Akira Ashida, Masashi Neo
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Objective This study explored the predictors of abemaciclib discontinuation, a cyclin-dependent kinase 4 and 6 inhibitor, in patients with breast cancer. Material and Methods Between November 2018 and March 2023, 147 patients with breast can
Externí odkaz:
https://doaj.org/article/b12607f23db64131ae5e485f6fc841be
Autor:
Kosei Kimura, Shigeru Kawabata, Hiroyo Oku, Ayana Ikari, Tomo Tominaga, Saki Takai, Junna Sakane, Michiaki Tanaka, Chinatsu Aoki, Monika Ota, Erika Minami, Yoshinobu Hirose, Sang-Woong Lee, Mitsuhiko Iwamoto
Publikováno v:
Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-5 (2022)
Abstract Background Accessory breast carcinomas of the axilla of males are rare, and primary breast neuroendocrine tumors (BNETs) are rare as well. We present a case of a BNET arising in the axilla of a man. Case presentation A 64-year-old Japanese m
Externí odkaz:
https://doaj.org/article/f00ca4e8ae79496187112d0091c15723
Autor:
Emi Goto, Takeo Hata, Masami Nishihara, Masashi Neo, Mitsuhiko Iwamoto, Kosei Kimura, Masahiro Goto, Yoshiyuki Rikitake
Publikováno v:
British Journal of Clinical Pharmacology.
Autor:
Yuki Otsuki, MD, PhD, Takashi Nuri, MD, PhD, Masashi Okada, MD, PhD, Koichi Ueda, MD, PhD, Hiroya Fujioka, MD, PhD, Kosei Kimura, MD, PhD, Mitsuhiko Iwamoto, MD, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 9, p e1920 (2018)
Summary:. A case of advanced breast carcinoma with large skin invasion that extended from the breast to the axilla and which was reconstructed with a meshed split skin graft for the chest defect and a posterior circumflex humeral artery perforator fl
Externí odkaz:
https://doaj.org/article/2f7e700bd1364e6abbcef90f7a3350f5
Autor:
EIKI YAMASAKI, FUKUTARO SHIMAMOTO, HIROKI NISHIKAWA, MASAHIRO GOTO, MITSUHIKO IWAMOTO, KOSEI KIMURA, AKIRA UKIMURA, NAOFUMI OOSAKA, KOHEI TANIGUCHI, FUMIHITO ONO, TETSUJI TERAZAWA, TOSHIFUMI YAMAGUCHI, KEN ASAISHI, TAKAKO IKEGAMI, KAZUHISA UCHIYAMA, SHIRO NAKAMURA, KAZUHIDE HIGUCHI
Publikováno v:
In Vivo
Background/Aim: To prospectively evaluate the efficacy and safety of the BNT162b2 vaccine in solid cancer patients undergoing systemic chemotherapy (n=63). Patients and Methods: COVID-19 anti-spike protein antibody levels were measured before the fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c481764c204061fd17818e0a98536c69
https://europepmc.org/articles/PMC9677789/
https://europepmc.org/articles/PMC9677789/
Autor:
Emi Goto, Takeo Hata, Masami Nishihara, Masashi Neo, Mitsuhiko Iwamoto, Kosei Kimura, Masahiro Goto, Yoshiyuki Rikitake
Aim To clarify the incidence and risk factors of infusion-related reactions (IRRs) to trastuzumab in breast cancer patients and verify the preventive effects of glucocorticoids. Methods The electronic medical record data at the time of trastuzumab ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76d1b7241de69a8d64c248381bb7fbe1
https://doi.org/10.22541/au.166082766.63141367/v1
https://doi.org/10.22541/au.166082766.63141367/v1
Autor:
Akiko Yumoto, Yuki Otsuki, Takashi Nuri, Erika Higashino, Kosei Kimura, Mitsuhiko Iwamoto, Koichi Ueda
Publikováno v:
Medicine. 102:e33672
Autor:
Kosei Kimura, Tsutomu Takashima, Hiroyo Oku, Ayana Ikari, Tomo Tominaga, Saki Takai, Junna Sakane, Michiaki Tanaka, Hidemi Kawajiri, Shinichiro Kashiwagi, Shinya Tokunaga, Shigehiko Nishimura, Satoru Noda, Mitsuhiko Iwamoto
Purpose: While the absolute lymphocyte count (ALC) and neutrophil-to-lymphocyte ratio (NLR) are associated with prolonged progression-free survival (PFS) and overall survival (OS), the influence of previous chemotherapy on blood cell counts may neces
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d405a80074f6350b2f89af226286bd5f
https://doi.org/10.21203/rs.3.rs-1614787/v1
https://doi.org/10.21203/rs.3.rs-1614787/v1
Autor:
Norihiro Hokimoto, Risa Terasawa, Tsutomu Takashima, Takashi Morimoto, Shintaro Michishita, Hirotaka Morishima, Shinichiro Kashiwagi, Junna Sakane, Yukihiro Nishida, Mitsuhiko Iwamoto, Satoru Noda, Nobuki Matsunami, Toshikatsu Nitta, Hiruya Fujioka, Kosei Kimura, Satoru Tanaka, Ayana Ikari, Nayuko Sato, Toshihiro Kobayashi, Yukie Tauchi, Naofumi Oda, Yuka Asano, Kanako Kawaguchi
Publikováno v:
Cancer Research. 80:P2-16
Background: Neoadjuvant anti-HER2 target agents combined with anthracycline and taxane is now considered a standard regimen for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. A less toxic, non-anthracycline regimen has been c
Autor:
Miki Yamaguchi, Hiroyuki Yasojima, Fuminori Aki, Fumie Fujisawa, Makiko Mizutani, Takahiro Nakayama, Katsuhide Yoshidome, Jun Yamamura, Junji Tsurutani, Yoshifumi Komoike, Tomomi Yamada, Hirotaka Morishima, Satoshi Morita, Mitsuhiko Iwamoto, Tsutomu Takashima, Norikazu Masuda, Masahiko Ikeda, Tetsuhiro Yoshinami
Publikováno v:
Cancer Research. 80:P3-12
Background: In the International Consensus Conference Guidelines for Advanced Breast Cancer, most experts agreed that the maintenance endocrine therapy after induction chemotherapy was reasonable. The combination therapy of bevacizumab (B) and paclit